Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celsion Corporation    CLSN

CELSION CORPORATION

(CLSN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CELSION CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

11/16/2020 | 08:48am EST

Item 2.02 Results of Operations and Financial Condition.

On November 16, 2020, Celsion Corporation issued a press release reporting its financial results for the quarter ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

On November 9, 2020, Celsion Corporation announced it would hold a conference call on November 16, 2020 to discuss its financial results for the quarter ended September 30, 2020 and provide a business update. The conference call will also be broadcast live on the internet at http://www.celsion.com.

The information in this report, including the exhibit hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. Such information shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by Celsion Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

The press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.     Description

 99.1       Press Release titled "Celsion Corporation Reports Third Quarter 2020
          Financial Results and Provides Business Update" issued by Celsion
          Corporation on November 16, 2020.

© Edgar Online, source Glimpses

All news about CELSION CORPORATION
01/22MIDDAY REPORT : Wall Street Drifts Lower Midday as IBM, Intel Slump
MT
01/22CELSION : to Raise $35 Million in Registered Direct Offering of Common Stock
MT
01/22Celsion corporation announces $35 million registered direct offering priced a..
GL
01/21CELSION CORP : Termination of a Material Definitive Agreement (form 8-K)
AQ
2020CELSION CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2020DEADLINE TODAY : The Schall Law Firm Announces it is Investigating Claims Agains..
BU
2020CELSION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2020CELSION CORP : Results of Operations and Financial Condition, Financial Statemen..
AQ
2020CELSION CORPORATION : Reports Third Quarter 2020 Financial Results and Provides ..
AQ
2020Celsion Corporation Reports Third Quarter 2020 Financial Results and Provides..
GL
More news
Financials (USD)
Sales 2020 0,50 M - -
Net income 2020 -23,3 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,88x
Yield 2020 -
Capitalization 51,3 M 51,3 M -
Capi. / Sales 2020 103x
Capi. / Sales 2021 -
Nbr of Employees 29
Free-Float 98,8%
Chart CELSION CORPORATION
Duration : Period :
Celsion Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELSION CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 3,00 $
Last Close Price 1,37 $
Spread / Highest target 119%
Spread / Average Target 119%
Spread / Lowest Target 119%
EPS Revisions
Managers and Directors
NameTitle
Michael H. Tardugno Chairman, President & Chief Executive Officer
Jeffrey Wayne Church CFO, Secretary & SVP-Investor Relations
Nicholas Borys Chief Medical Officer & Senior Vice President
Khursheed Anwer Chief Scientific Officer & Executive VP
Pok Yu Chow Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CELSION CORPORATION92.69%51
GILEAD SCIENCES, INC.14.90%83 911
WUXI APPTEC CO., LTD.36.65%66 044
VERTEX PHARMACEUTICALS0.53%61 782
REGENERON PHARMACEUTICALS11.32%56 760
BEIGENE, LTD.44.94%34 148